(marketscreener.com) IRVINE, Calif., Oct. 18, 2021 -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement systems, today announced the first commercial implants with the Trilogy Heart Valve System in Europe. The procedures, which included treatment of both aortic regurgitation1 and aortic...https://www.marketscreener.com/news/latest/JenaValve-Announces-First-European-Commercial-Implants-with-the-Trilogy-trade-Heart-Valve-System--36711105/?utm_medium=RSS&utm_content=20211018